These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 33217427)
1. Comparative Assessment of Extrapolation Methods Based on the Conventional Free Drug Hypothesis and Plasma Protein-Mediated Hepatic Uptake Theory for the Hepatic Clearance Predictions of Two Drugs Extensively Bound to Both the Albumin And Alpha-1-Acid Glycoprotein. Bteich M; Poulin P; Haddad S J Pharm Sci; 2021 Mar; 110(3):1385-1391. PubMed ID: 33217427 [TBL] [Abstract][Full Text] [Related]
2. Extrapolation of the Hepatic Clearance of Drugs in the Absence of Albumin In Vitro to That in the Presence of Albumin In Vivo: Comparative Assessement of 2 Extrapolation Models Based on the Albumin-Mediated Hepatic Uptake Theory and Limitations and Mechanistic Insights. Poulin P; Haddad S J Pharm Sci; 2018 Jul; 107(7):1791-1797. PubMed ID: 29567347 [TBL] [Abstract][Full Text] [Related]
3. Supplemental Analysis of the Prediction of Hepatic Clearance of Binary Mixtures of Bisphenol A and Naproxen Determined in an Isolated Perfused Rat Liver Model to Promote the Understanding of Potential Albumin-Facilitated Hepatic Uptake Mechanism. Poulin P; Bteich M; Haddad S J Pharm Sci; 2017 Nov; 106(11):3207-3214. PubMed ID: 28823401 [TBL] [Abstract][Full Text] [Related]
4. First-in-Human Predictions of Hepatic Clearance for Drugs With the Well-Stirred Model: Comparative Assessment Between Models of Fraction Unbound Based Either on the Free Drug Hypothesis, Albumin-Facilitated Hepatic Uptake or Dynamic Binding Kinetics. Poulin P J Pharm Sci; 2024 Aug; 113(8):2641-2650. PubMed ID: 38796154 [TBL] [Abstract][Full Text] [Related]
5. Impact of Extensive Plasma Protein Binding on the In Situ Hepatic Uptake and Clearance of Perampanel and Fluoxetine in Sprague Dawley Rats. Bteich M; Poulin P; Piette S; Haddad S J Pharm Sci; 2020 Oct; 109(10):3190-3205. PubMed ID: 32649937 [TBL] [Abstract][Full Text] [Related]
6. The potential protein-mediated hepatic uptake: discussion on the molecular interactions between albumin and the hepatocyte cell surface and their implications for the in vitro-to-in vivo extrapolations of hepatic clearance of drugs. Bteich M; Poulin P; Haddad S Expert Opin Drug Metab Toxicol; 2019 Aug; 15(8):633-658. PubMed ID: 31274340 [No Abstract] [Full Text] [Related]
7. Albumin and Uptake of Drugs in Cells: Additional Validation Exercises of a Recently Published Equation that Quantifies the Albumin-Facilitated Uptake Mechanism(s) in Physiologically Based Pharmacokinetic and Pharmacodynamic Modeling Research. Poulin P; Haddad S J Pharm Sci; 2015 Dec; 104(12):4448-4458. PubMed ID: 26457988 [TBL] [Abstract][Full Text] [Related]
8. Improving Prediction of Metabolic Clearance Using Quantitative Extrapolation of Results Obtained From Human Hepatic Micropatterned Cocultures Model and by Considering the Impact of Albumin Binding. Da-Silva F; Boulenc X; Vermet H; Compigne P; Gerbal-Chaloin S; Daujat-Chavanieu M; Klieber S; Poulin P J Pharm Sci; 2018 Jul; 107(7):1957-1972. PubMed ID: 29524447 [TBL] [Abstract][Full Text] [Related]
9. Prediction of total hepatic clearance by combining metabolism, transport, and permeability data in the in vitro-in vivo extrapolation methods: emphasis on an apparent fraction unbound in liver for drugs. Poulin P J Pharm Sci; 2013 Jul; 102(7):2085-95. PubMed ID: 23613473 [TBL] [Abstract][Full Text] [Related]
10. An overview of interpretability of two models of unbound fraction that are used in combination with the well-stirred model for predicting hepatic clearance of drugs. Poulin P J Pharm Sci; 2024 Nov; 113(11):3177-3190. PubMed ID: 39265660 [TBL] [Abstract][Full Text] [Related]
11. Predictions of bisphenol A hepatic clearance in the isolated perfused rat liver (IPRL): impact of albumin binding and of co-administration with naproxen. Bounakta S; Bteich M; Mantha M; Poulin P; Haddad S Xenobiotica; 2018 Feb; 48(2):135-147. PubMed ID: 28277163 [TBL] [Abstract][Full Text] [Related]
12. A New Guidance for the Prediction of Hepatic Clearance in the Early Drug Discovery and Development from the in Vitro-to-in Vivo Extrapolation Method and an Approach for Exploring Whether an Albumin-Mediated Hepatic Uptake Phenomenon Could be Present Under in Vivo Conditions. Poulin P; Haddad S J Pharm Sci; 2021 Jul; 110(7):2841-2858. PubMed ID: 33857483 [TBL] [Abstract][Full Text] [Related]
13. Quantitative Estimation of Plasma Free Drug Fraction in Patients With Varying Degrees of Hepatic Impairment: A Methodological Evaluation. Li GF; Yu G; Li Y; Zheng Y; Zheng QS; Derendorf H J Pharm Sci; 2018 Jul; 107(7):1948-1956. PubMed ID: 29518400 [TBL] [Abstract][Full Text] [Related]
14. Consideration of albumin-mediated hepatic uptake for highly protein-bound anionic drugs: Bridging the gap of hepatic uptake clearance between in vitro and in vivo. Miyauchi S; Kim SJ; Lee W; Sugiyama Y Pharmacol Ther; 2022 Jan; 229():107938. PubMed ID: 34171335 [TBL] [Abstract][Full Text] [Related]
15. A 20-Year Research Overview: Quantitative Prediction of Hepatic Clearance Using the In Vitro-In Vivo Extrapolation Approach Based on Physiologically Based Pharmacokinetic Modeling and Extended Clearance Concept. Sugiyama Y; Aoki Y Drug Metab Dispos; 2023 Sep; 51(9):1067-1076. PubMed ID: 37407092 [TBL] [Abstract][Full Text] [Related]
16. Impact of Plasma Protein Binding in Drug Clearance Prediction: A Data Base Analysis of Published Studies and Implications for In Vitro-In Vivo Extrapolation. Francis LJ; Houston JB; Hallifax D Drug Metab Dispos; 2021 Mar; 49(3):188-201. PubMed ID: 33355201 [TBL] [Abstract][Full Text] [Related]
17. Extrapolation of In Vivo Hepatic Clearance from In Vitro Uptake Clearance by Suspended Human Hepatocytes for Anionic Drugs with High Binding to Human Albumin: Improvement of In Vitro-to-In Vivo Extrapolation by Considering the "Albumin-Mediated" Hepatic Uptake Mechanism on the Basis of the "Facilitated-Dissociation Model". Kim SJ; Lee KR; Miyauchi S; Sugiyama Y Drug Metab Dispos; 2019 Feb; 47(2):94-103. PubMed ID: 30504137 [TBL] [Abstract][Full Text] [Related]
18. Toward a new paradigm for the efficient in vitro-in vivo extrapolation of metabolic clearance in humans from hepatocyte data. Poulin P; Haddad S J Pharm Sci; 2013 Sep; 102(9):3239-51. PubMed ID: 23494893 [TBL] [Abstract][Full Text] [Related]
19. In vitro-in vivo extrapolation of clearance: modeling hepatic metabolic clearance of highly bound drugs and comparative assessment with existing calculation methods. Poulin P; Kenny JR; Hop CE; Haddad S J Pharm Sci; 2012 Feb; 101(2):838-51. PubMed ID: 22009717 [TBL] [Abstract][Full Text] [Related]
20. Facing the Facts of Altered Plasma Protein Binding: Do Current Models Correctly Predict Changes in Fraction Unbound in Special Populations? Al-Qassabi J; Tan SPF; Phonboon P; Galetin A; Rostami-Hodjegan A; Scotcher D J Pharm Sci; 2024 Jun; 113(6):1664-1673. PubMed ID: 38417790 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]